These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2807362

  • 1. Comparative efficacy of atenolol and labetalol in essential hypertension--a double blind cross over trial.
    Srivastava SC, Jagdish, Katyal VK, Singh H, Mohan R.
    Indian Heart J; 1989; 41(4):256-60. PubMed ID: 2807362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J, Zech PY, Pozet N, Cuisinaud G, Vincent M.
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enalapril as a first-step agent in essential hypertension: a comparative study with atenolol.
    Edmonds D, Greminger P, Locher R, Knorr M, Vetter H, Vetter W.
    J Hypertens Suppl; 1986 Dec; 4(5):S406-9. PubMed ID: 3033180
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamic effects of prazosin combinations during dynamic and isometric exercise.
    Lilja M, Ikäheimo M, Mattila MJ, Jounela AJ.
    Ann Clin Res; 1985 Dec; 17(6):316-22. PubMed ID: 3913379
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B, Keller SE, Makris L, Goldberg AI, Sweet CS, Lim NY.
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
    Nilsson OR, Karlberg BE, Henningsen NC, Thulin T.
    Acta Med Scand Suppl; 1982 Jun; 665():117-9. PubMed ID: 6760679
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.